Ipca Laboratories
Update in progressIPCALAB.NS (NSE)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
Ipca Laboratories Limited is an integrated pharmaceutical company that develops and manufactures formulations and active pharmaceutical ingredients (APIs). It serves India, Europe, Africa, the Americas, Asia, the CIS and Australasia, and exports worldwide. Ipca offers APIs in anti-hypertensive, anti-malarial, diuretic, DMARD and anthelmintic areas, and markets generic and branded formulations across many therapeutic domains, including cardiology, diabetes, dermatology, and neurology. Incorporated in 1949 and based in Mumbai.
Company score
- Sentiment
- 0.05
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.00
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.03
- Governance
- -0.16
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- -0.02
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.01
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Sort by
Order by
Timeframe
No news articles are available for this company yet.
Unable to load company news.
Loading more news
You're all caught up!